Transcarent recently announced that it raised $126 million in Series D funding led by General Catalyst and 7wireVentures. When asked what his exit strategy is, CEO Glen Tullman said he does not want to sell Transcarent, but sees an initial public offering as an option. The post Glen Tullman Has ‘No Interest’ In Selling Transcarent, But IPO Is a Possibility...

Balancing the promise of personalized medicine with proper payment accuracy The post Navigating the Complexities of Payment for Genetic Testing appeared first on MedCity News.

Geneoscopy received approval for its noninvasive colorectal cancer screening test, which the FDA designated as a breakthrough device. This marks only the second time the FDA has issued an approval for a molecular diagnostic test for colorectal cancer — and the first time the agency has done so for a colorectal cancer test that uses RNA. The post FDA...

More than a third of employers are integrating accountable care into their health benefits, according to a new report from the Milken Institute. However, there are several barriers. The post Report: More Employers Are Looking To Deploy Value-Based Care appeared first on MedCity News.

There is a growing urgency for alternative solutions that support consumers where they are, and this is where the promise of digital health can be transformative.  The post Tech-Driven Healthcare: Paving the Way for Scalable Solutions  appeared first on MedCity News.

This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision making via elevated awareness. With the right tools in place, organizations can expedite strategic achievement across every area of the system. The post Using Informed Awareness to Transform Care Coordination and Improve...